Pharmacological treatments in panic disorder in adults: a network meta-analysis
Alprazolam performs well for short-term panic relief in trials - how do we balance that against dependence risk if I end up needing treatment for months, not weeks?
Well-supported by good-quality research. how we score evidence
Across 70 randomized trials (up to 12,310 people in the largest analysis), alprazolam was among the most effective and best-tolerated drugs for panic disorder, and one of only two that clearly reduced panic-attack frequency versus placebo, though the review judged the underlying trial quality low enough to limit confidence.
Worth asking
Alprazolam performs well for short-term panic relief in trials - how do we balance that against dependence risk if I end up needing treatment for months, not weeks?
What it is FDA approved for
Read off the label. Trial duration and approval year are shown only where they were recorded — never inferred.
- Generalized anxiety disorder (acute treatment)
- Panic disorder, with or without agoraphobia
Source
Pharmacological treatments in panic disorder in adults: a network meta-analysis — Guaiana G, et al. (2023)
Top-tier peer-reviewed journal
Read the source: https://doi.org/10.1002/14651858.CD012729.pub3
DOI: 10.1002/14651858.CD012729.pub3
How this was scored
- Study design
- Meta-analysis of randomised trials
- Funding
- Funding not disclosed
- Published in
- Top-tier peer-reviewed journal
- Sample size
- 12,310
- Preregistered
- Yes
- Conflicts disclosed
- No
- Independent of proponent
- not recorded
- Retracted
- No
Read the full scoring rubric, including what it can't tell you.
Published August 19, 2026.
Questions
How strong is the evidence behind this?
Resolv rates this source "strong evidence". Well-supported by good-quality research. It scores 79 out of 100 on our published rubric. The score is calculated from recorded facts about the source — study design, funding, publication venue, sample size, preregistration — not typed in by an editor.
What is the source for this?
Pharmacological treatments in panic disorder in adults: a network meta-analysis — Guaiana G, et al. (2023). Published in: Top-tier peer-reviewed journal. DOI: 10.1002/14651858.CD012729.pub3. The full source is linked on this page so you can read it yourself.
Who paid for this research, and does that matter?
Study design: Meta-analysis of randomised trials. Funding: Funding not disclosed. Independence from the proponent is not recorded. Industry sponsorship is one of the most reliably measured biases in medicine, which is why funding carries real weight in the score rather than sitting in a footnote.
Is alprazolam (Xanax), xanax FDA approved?
Yes — FDA approved for Generalized anxiety disorder (acute treatment), Panic disorder, with or without agoraphobia. Approval is for a specific indication, not for everything the drug is prescribed for.
Is this medical advice?
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.
This is information to bring to your prescriber, not medical advice and not a reason to change anything on your own. Nothing here is an instruction to stop or reduce a medication. If you are in crisis, call or text 988.